clinical trial · NCT05925114
Safety and Efficacy Study of S-309309 in Obese Adults
Shionogi·phase2·completed·n = 365
ObesityS-309309Placebo
brief summary
The primary objective of this study is to understand the efficacy of S-309309 on the body weight of obese adults.
started
Jun 21, 2023
primary completion
Apr 15, 2024
completion
May 17, 2024
last updated
Apr 16, 2025
official title
A Phase 2, Multicenter, Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Assess the Safety and Efficacy of S-309309 in Obese Adults
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol